SYNC: A Protein Involved in TGF-β Pathway and Neurological Disorders

Target Name: SYNC

NCBI ID: G81493

SYNC

SYNC: A Protein Involved in TGF-β Pathway and Neurological Disorders

SYNC (SYNC variant 1) is a protein that is expressed in the brain and is involved in the regulation of cell signaling pathways. It has been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease and Parkinson's disease. As a result, SYNC has become a focus of interest for researchers as a potential drug target or biomarker.

SYNC is a key regulator of the TGF-β pathway, which is a well-established pathway involved in the development and maintenance of neural stem cells and the development of various neurological disorders. The TGF-β pathway is a critical regulator of cell proliferation, differentiation, and survival, and is involved in the development of neural stem cells, including those that give rise to the brain.

SYNC is a key regulator of the TGF-β pathway in the brain, and it has been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease and Parkinson's disease. Studies have shown that individuals with certain genetic variations in the SYNC gene are at increased risk for developing these disorders.

One of the key features of SYNC is its ability to interact with other proteins, including the TGF-β receptor. The TGF-β receptor is a key regulator of cell signaling pathways, and is involved in the development and maintenance of neural stem cells and the development of various neurological disorders. By interacting with the TGF-β receptor, SYNC has been shown to play a role in regulating the activity of this receptor and in the development of neural stem cells.

In addition to its role in the TGF-β pathway, SYNC has also been shown to play a role in the regulation of cell signaling pathways that are involved in the development and maintenance of neural stem cells. For example, studies have shown that SYNC is involved in the regulation of the Wnt signaling pathway, which is involved in the development and maintenance of neural stem cells.

SYNC is also involved in the regulation of the Notch signaling pathway, which is involved in the development and maintenance of neural stem cells. Notch signaling is a critical regulator of neural stem cell survival and proliferation, and is involved in the development and progression of various neurological disorders.

SYNC is a protein that is expressed in the brain, and it has been shown to play a role in the regulation of cell signaling pathways that are involved in the development and maintenance of neural stem cells. Its role in these processes makes it a potential drug target or biomarker for the development of various neurological disorders. Further research is needed to fully understand the role of SYNC in the development and progression of these disorders, and to determine the most effective way to target or use it as a biomarker.

Protein Name: Syncoilin, Intermediate Filament Protein

Functions: Atypical type III intermediate filament (IF) protein that may play a supportive role in the efficient coupling of mechanical stress between the myofibril and fiber exterior. May facilitate lateral force transmission during skeletal muscle contraction. Does not form homofilaments nor heterofilaments with other IF proteins

The "SYNC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYNC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets